Exocell—糖尿病研究相關(guān)產(chǎn)品
Exocell公司是一家專注于糖尿病及其并發(fā)癥研究相關(guān)的產(chǎn)品與服務(wù)美國高科技生物制品公司，該公司提供先進的糖尿病研究產(chǎn)品，涵蓋臨床診斷、臨床研究及基礎(chǔ)實驗研究領(lǐng)域，包括人、小鼠、 大鼠尿蛋白和糖基化蛋白，人纖連蛋白、載脂蛋白B等一系列試劑盒和抗體，其高品質(zhì)的產(chǎn)品歐美。作為開發(fā)，營銷和執(zhí)行新的臨床診斷化驗*者，Exocell公司已經(jīng)并且正在為糖尿病及其相關(guān)的腎臟和血管疾病領(lǐng)域的基礎(chǔ)科研、實驗動物研究以及臨床診斷和治療研究提供的產(chǎn)品和研發(fā)服務(wù)。
Exocell公司的主要產(chǎn)品：
一、臨床診斷檢測對于糖尿病及其并發(fā)癥的治療和管理至關(guān)重要，在該領(lǐng)域中Exocell公司提供的臨床診斷相關(guān)產(chǎn)品包括：
Albuwell用于檢測微白蛋白尿，是早期糖尿病性腎功能紊亂的明確標(biāo)志物。
Creatinine用于檢測尿中的creatinine.
Glycaben用于監(jiān)測糖化白蛋白（中期的控糖指標(biāo)）
Glycacor用于檢測糖化LDL（短期控糖指標(biāo)及心血管疾病風(fēng)險指標(biāo)）
Hemoglobin A1c參照標(biāo)準(zhǔn)（長期控糖指標(biāo)）
二、臨床研發(fā)類檢測試劑與試劑盒測定大量人類糖尿病及其并發(fā)癥的重要指標(biāo)，在該領(lǐng)域中Exocell公司提供的相關(guān)產(chǎn)品包括：
Apo B Test用于檢測人血漿中的apolipoprotein B
Collagen IV H用于檢測 樣本中的IV 型膠原
hFibronectin ELISA試劑盒用于檢測人血漿中的fibronectin
Nephrin ELISA試劑盒用于檢測尿液中的nephrin.
h-PODXL用于檢測人組織或尿液樣本中的podocalyxin
Beta-induced h3用于檢測人尿液中的BIG-H3，
Troponin – H用于檢測人血漿或血清中的 Troponin I，
TNF-sR2 用于檢測人尿/血漿/血清中的TNF-α可溶性受體2
三、Exocell公司提供的糖尿病及其并發(fā)癥的實驗室研究相關(guān)產(chǎn)品，包括：
Albuwell M用于檢測小鼠樣本中的微白蛋白尿，
Nephrat II用于檢測大鼠樣本中的微白蛋白尿，
Albuwell C, O 及 P 用于檢測狗、綿羊及非人的靈長類動物樣本中的微白蛋白尿，
Collagen IV M用于檢測小鼠和大鼠樣本中的IV型膠原，
Creatinine Companion用于檢測人和嚙齒類動物的creatinine.
Glyco-Albumin R用于檢測大鼠血清中的糖化白蛋白，
Nephrin ELISA to measure rodent urinary nephrin.
CRP ELISA試劑盒用于檢測嚙齒類動物血漿中的C-reactive蛋白.
Adiponectin ELISA試劑盒用于檢測人尿和血漿中的adiponectin，
Beta-induced h3用于檢測人尿中的BIG-H3，
Troponin M用于檢測小鼠血漿/血清中的Troponin I，
Troponin R用于檢測大鼠血漿/血清中的Troponin I，
PODXL–R用于檢測嚙齒類動物尿液中的podpcalyxin ，
四、糖尿病及其并發(fā)癥研究相關(guān)的試劑及標(biāo)準(zhǔn)參照品，包括高特異性的單克隆抗體及高度純化的蛋白，，在該領(lǐng)域中Exocell公司提供的相關(guān)產(chǎn)品包括：
A717:抗糖化白蛋白單克隆抗體
E85: 抗糖化血紅素的單克隆抗體
ES12:抗糖化LDL的單克隆抗體
糖化血紅素片段(gly Hb, HbA1c, glyHbA0, HbA1a, b)
去糖的血紅素片段(degly Hb, degly HbA0)
糖化的白蛋白(NGA/SGA)
去糖化的白蛋白
部分使用Exocell公司產(chǎn)品的相關(guān)文獻：
1、Albuwell M：
- American Journal Physiology Renal Physiology 293:F1657-1665, 2007
Interference with TGF-B signalling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria - American Journal Physiology Renal Physiology 292:F321-329, 2007
Soluble betaglycan reduces renal damage progression in db/db mice - Nephron Experimental Nephrology 105:e45-e52, 2007
Amelioration of established diabetic nephropathy by combined treatment with SMP-534 (antifibrotic agent) and losartan in db/db mice - American Journal Physiology Renal Physiology 290:F214-F222, 2006
Impact of genetic background on nephropathy in diabetic mice - American Journal Physiology Heart Circ Physiology 290:H935-H940, 2006
Angiotensin II hypertension is attenuated in interleukin-6 knockout mice - American Journal Physiology Renal Physiology 291:F1315-F1322, 2006
Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes - American Journal Physiology Renal Physiology 290:F813-820, 2006
SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice - American Journal Physiology Renal Physiology 290:F828-F837, 2006
Adenosine A2a receptor activation attenuates inflammation and injury in diabetic nephropathy - Nephron Experimental Nephrology 104:e23-e34, 2006
Plasminogen activator inhibitor-1 deficiency has renal benefits but some adverse systemic consequences in diabetic mice - Journal American Society Nephrology 16:27-45, 2005
Mouse models of diabetic nephropathy - American Society Nephrology 16:1289-1299, 2005
Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23 - Diabetes 54:2628-2637, 2005
Characterization of susceptibility of inbred mouse strains to diabetic nephropathy - American Journal Pathology 165:1243-1255, 2004
Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules - Hypertension 43:364-369, 2004
Role for thromboxanes receptors in angiotensin-II-induced hypertension - Journal Clinical Investigation 113:1390-1397, 2004
Induction of B7-1 in podocytes is associated with nephritic syndrome - Diabetes 53:2101-2109, 2004
Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-?-deficient mice - Journal American Society Nephrology 14:1200-1211, 2003
Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant ?-actinin-4 - American Journal Pathology 162:1123-1137, 2003
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy - Kidney International 64:1978-1985, 2003
Gene expression profile in diabetic KK/Ta mice - Journal of Immunology 170:5658-5666, 2003
CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration
2、Glycacor：
- Atherosclerosis 202:162-168, 2009
Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro - Immunopharmacology Immunotoxicology 15:1-12, 2008
Evaluation of serum biomarkers in nutritional disorders: Glycated apolipoprotein B, fasting serum glucose, fructosamine, stable and labile glycated hemoglobin in diabetic and non-diabetic subjects - Nutrition Metabolism & Cardiovascular Disease 17:6-12, 2007
Glycated apolipoprotein B and myocardial infarction - Circulation 109:1750-1755, 2004
Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes - Diabetes Technology & Therapeutics 6:348-356, 2004
Increased plasma glycated low-density lipoprotein concentrations in diabetes: A marker of atherogenic risk - Journal American Society Nephrology 10:332-341, 1999
Non-insulin dependent diabetes mellitus and hypertriglyceridemia impair lipoprotein metabolism in chronic hemodialysis patients - Nephrology Dialysis Transplantation 12:1336-1343, 1997
Uptake and metabolism of lipoproteins from patients with diabetes mellitus type II by glomerular epithelial cells
3、Nephrat：
- Cell Biochemistry Biophysics 48:147-157, 2007
Novel inhibitors of glycation and AGE formation - American Journal Physiology Regul Integr Comp Physiology 292:R769-R777, 2007
17-estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney - Diabetes 56:1842-1849, 2007
Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation - American Journal Physiology Renal Physiology 290:F828-F837, 2006
Adenosine A2a receptor activation attenuates inflammation and injury in diabetic nephropathy - Laboratory Investigation 86:357-368, 2006
Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy - FASEB Journal 20:E150-E159, 2006
Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers - American Journal Physiology Regul Integr Comp Physiology 290:R435-R441, 2006
Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes - Laboratory Investigation 86:927-939, 2006
Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy - American Journal Physiology Renal Physiology 289:F442-450, 2005
Regulation of the renal thiazide-sensitive Na-Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone - Diabetologia 46:1140-1152, 2003
LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats - Journal American Society Nephrology 14:709-720, 2003
Delayed treatment with lithospermate B attenuates experimental diabetic renal injury - Journal American Society Nephrology 14:3178-3187, 2003
Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen ?5(IV) in experimental diabetic nephropathy and ion glucose-stimulated podocytes - American Journal Pathology 158:1733-1741, 2001
A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis - American Journal Society Nephrology 12:993-1000, 2001
Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes
4、Collagen Type IV
- Diabetologia 51:198-207, 2008
Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells - Nephron Experimental Nephrology 105:e45-e52, 2007
Amelioration of established diabetic nephropathy by combined treatment with SMP-534 (antifibrotic agent) and losartan in db/db mice - American Journal Physiology Renal Physiol 292:F789-F795, 2007
Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency - American Journal Physiology Renal Physiology 290:F813-820, 2006
SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice - Kidney International 68:1554-1561, 2005
Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy - Kidney International 64:1632-1642, 2003
Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells - Metabolism 50:1435-1440, 2001
Increased urinary type IV collagen marks the development of glomerular [athology in diabetic db/db mice - Diabetes Care 24:914-918, 2001
Increased collagen IV excretion in diabetes - Diabetes Care 24:1324-1327, 2001
Serum type IV collagen in diabetic patients at risk for nephropathy
5、Nephrin：
- PLoS One 7(5):e36041, 2012
Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: A cross sectional study - Am J Physiol Renal Physiol 302:F1084-F1089, 2012
Increased urinary excretion of nephrin, podocalyxin and ?ig-h3 in women with preeclampsia
6、Podocalyxin：
- Am J Physiol Renal Physiol 302:F1084-F1089, 2012
Increased urinary excretion of nephrin, podocalyxin and βig-h3 in women with preeclampsia
7、 βig-h3：
- Am J Physiol Renal Physiol 302:F1084-F1089, 2012
Increased urinary excretion of nephrin, podocalyxin and βig-h3 in women with preeclampsia
詳細(xì)公司及產(chǎn)品信息請訪問：http://www.exocell。。ｃｏｍ/
世界*實驗材料供應(yīng)商Exocell正式授權(quán)上海起發(fā)為其中國代理，Exocell在一直是行業(yè)的*,一直為廣大科研客戶提供zui為的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為中國科研客戶帶來的產(chǎn)品，的服務(wù)， 簽約Exocell就是為了給廣大科研客戶帶來更加完善的產(chǎn)品和服務(wù),您的滿意將是我們zui大的收獲
Exocell中國代理，Exocell上海代理，Exocell北京代理，Exocell廣東代理，Exocell江蘇代理 Exocell湖北代理, Exocell天津, Exocell黑龍江代理, Exocell內(nèi)蒙古代理, Exocell吉林代理, Exocell福建代理, Exocell江蘇代理, Exocell浙江代理, Exocell四川代理,
我們公司zui大優(yōu)勢是強大的采購，
1：基本什么都能進口，血清，抗體，耗材，還有部分限制進口的，
2： 貨品全，現(xiàn)經(jīng)營過700多個品牌，基本所有生物試劑耗材都可以進口，特別是冷偏的產(chǎn)品那就更有優(yōu)勢，
3：提供加急服務(wù)，一般1-2周到貨，超過時限加急費全免
4：價格公道，絕大部分價格有優(yōu)勢，當(dāng)然不能保證100%產(chǎn)品都是,因為意味著沒有服務(wù).
5：良好的信譽，大部分客戶我們提供貨到付款服務(wù)，客戶包括清華，北大 交大 復(fù)旦，中山等100多所大學(xué)，ROCHE，阿斯利康，國藥 ，fisher等500多家公司
6：我們還是santa,Advanced Biotechnologies Inc;Athens Research & Technology, bangs, BBInternational, crystalchem, dianova, FD Neurotechnologies, Inc. FormuMax Scientific, Inc; Genebridege; Glycotope Biotechnology GmbH; iduron; Innovative Research of America； Ludger ； neuroprobe; omicronbio; Polysciences; prospecbi; QA-BIO；quickzyme；RESEARCH DIETS, INC；sterlitech；sysy；TriLink BioTechnologies, Inc；worthington-biochem;zyagen;......幾十家國外公司授權(quán)代理
7：我們還從事invitrogen，qiagen; abcam ;sigma;neb; roche;merck; rnd; BD; GE; pierce; BioLegend....等*批發(fā)
地址：上海浦東川沙鎮(zhèn)川沙路6619號上海起發(fā)實驗試劑有限公司
郵箱：xs1@78bio.com
傳真：021-50724961
當(dāng)前位置：